APMD 10-K & 10-Q changes, risk factors and insider trading

Apnimed, Inc. · Nasdaq · Pharmaceutical Preparations · CIK 1745648 · All filings on SEC.gov

Everything below is quoted or computed from Apnimed, Inc.'s public SEC filings. It is not a recommendation to buy or sell. Automated comparisons can contain errors; confirm with the original filing.

At a glance

2Form 4 filings reporting open-market purchases (last 180 days)

0Form 4 filings reporting open-market sales (last 180 days)

Jump to: Annual report (10-K) · Quarterly report (10-Q) · Insider transactions · 13F holders

What changed in the latest 10-K

Comparison not available: Not available: fewer than two 10-K filings on EDGAR to compare..

What changed in the latest 10-Q

Comparison not available: Not available: fewer than two 10-Q filings on EDGAR to compare (only one so far)..

APMD insider buying and selling (Form 4)

Since 2026-04-11, insiders reported open-market purchases in 2 Form 4 filings (2 insiders, 1 trade date, 325,000 shares, about $5.2M) and open-market sales in 0 filings. Net open-market shares: 325,000 (purchases minus sales); net value about $5.2M.Totals add up every open-market (code P and S) line in those filings, using the prices reported in the filings. Awards, option exercises, tax withholding and gifts are listed below but not counted.

Trade date	Insider	Transaction	Shares	Price	Value	Owned after	Filing
2026-08-03	Morningside Venture Investments Ltd 10% owner	Other	6,840,213	—	—	6,840,213	SEC
2026-08-03	Morningside Venture Investments Ltd 10% owner	Conversion	6,840,213	—	—	6,840,213	SEC
2026-08-03	Morningside Venture Investments Ltd 10% owner	Other	6,840,213	—	—	0	SEC
2026-08-03	Morningside Venture Investments Ltd 10% owner	Open-market purchase	312,500	$16.00	$5.0M	7,152,713	SEC
2026-08-03	Morningside Venture Investments Ltd 10% owner	Other	75,624	—	—	75,624	SEC
2026-08-03	Morningside Venture Investments Ltd 10% owner	Other	75,624	—	—	0	SEC
2026-08-03	Morningside Venture Investments Ltd 10% owner	Conversion	75,624	$14.40	$1.1M	75,624	SEC
2026-08-03	Lunate Holding Rsc Ltd 10% owner	Conversion	1,512,480	$13.50	$20.4M	7,054,956	SEC
2026-08-03	Lunate Holding Rsc Ltd 10% owner	Conversion	534,214	—	—	1,535,865	SEC
2026-08-03	Lunate Holding Rsc Ltd 10% owner	Conversion	1,001,651	—	—	1,001,651	SEC
2026-08-03	Lunate Holding Rsc Ltd 10% owner	Conversion	4,006,611	—	—	5,542,476	SEC
2026-08-03	Sekhri Paul J Director	Open-market purchase	12,500	$16.00	$200.0K	12,500	SEC
2026-08-03	Miller Lawrence G. Director	Disposition to issuer	92,431	—	—	0	SEC
2026-08-03	Miller Lawrence G. Director	Disposition to issuer	88,954	—	—	0	SEC
2026-08-03	Miller Lawrence G. Director	Grant/award	88,954	—	—	88,954	SEC
2026-08-03	Miller Lawrence G. Director	Grant/award	92,431	—	—	92,431	SEC
2026-08-03	Miller Lawrence G. Director	Conversion	10,845	—	—	103,276	SEC
2026-08-03	Miller Lawrence G. Director	Disposition to issuer	88,954	—	—	0	SEC
2026-08-03	Miller Lawrence G. Director	Grant/award	88,954	—	—	88,954	SEC
2026-08-03	Miller Lawrence G. Director	Disposition to issuer	88,954	—	—	0	SEC
2026-08-03	Miller Lawrence G. Director	Grant/award	88,954	—	—	88,954	SEC
2026-08-03	Miller Lawrence G. Director	Disposition to issuer	88,954	—	—	0	SEC
2026-08-03	Miller Lawrence G. Director	Grant/award	88,954	—	—	88,954	SEC
2026-08-03	Molnar Dennis Patrick President	Grant/award	58,014	—	—	58,014	SEC
2026-08-03	Molnar Dennis Patrick President	Disposition to issuer	58,014	—	—	0	SEC

Well-known investors holding APMD (13F)

None of the 59 investors we track reported a position in their latest 13F.

Coming soon: email alerts when APMD files, watchlists and downloadable comparisons.